Loading...

DeGette, Bucshon Lead Bipartisan Push to Improve Diagnostic Testing

July 14, 2021 by TWN Staff
DeGette, Bucshon Lead Bipartisan Push to Improve Diagnostic Testing

WASHINGTON – Reps. Diana DeGette, D-Colo., and Dr. Larry Bucshon, R-Ind., are leading a renewed bipartisan drive to improve the nation’s diagnostic testing capabilities and ensure hospitals and laboratories across the country are better able to respond to future national health emergencies, such as the COVID-19 pandemic.

The legislation is known as the Verifying Accurate, Leading-edge IVCT Development, or VALID, Act. An identical version of the bill – sponsored by Sens. Michael Bennet, D-Colo., and Richard Burr, R-N.C., has been introduced in the Senate.

It would, among other things, permanently lift a Food and Drug Administration requirement that all diagnostic tests used to screen patients during a declared public health emergency be approved by the agency before they are used to diagnose the emerging threat.

Instead, under the terms of the bill, hospitals and labs that have validated their tests – and provided that data to FDA – would be able to start using them immediately to screen patients as FDA considers their application for emergency use.

The legislation also seeks to address concerns raised by public health officials in the early stages of the pandemic that the FDA policy in place at the outset of the pandemic impeded their ability to quickly and efficiently respond to the virus and, when necessary, quarantine those who had become infected.

“If we’ve learned anything from combating the spread of highly contagious viruses – such as MERS, SARS, Ebola and now COVID-19 – it’s that time is of the essence,” DeGette said. “We can’t allow an outdated and inefficient system to hold us back when trying to respond to an emerging threat, such as the coronavirus. 

“This legislation will ensure that our hospitals and laboratories have the ability to respond quickly, accurately and efficiently to help us detect and stop the spread of these diseases before it’s too late,” she said.

In addition to removing the FDA’s pre-approval requirement for tests used to screen patients during future public health emergencies, DeGette and Bucshon’s legislation would completely overhaul how the federal government reviews and approves all diagnostic tests going forward.

Among other things, it would create an entirely new product category for diagnostic and lab tests, putting their review and approval squarely under the FDA. 

It would also create a new system that would allow hospitals and labs to submit their tests to the FDA electronically, a change that would improve the agency’s ability to oversee their quality and reliability, while at the same time drastically reducing the time it takes the agency to review them.

Additionally, the VALID Act would establish a program to expedite the development and review of new diagnostic tests that seek to address a current unmet need for patients. And it includes a provision to grandfather in any tests currently available to patients in the U.S. so it doesn’t – in any way – impede the ability of health care providers to continue testing and treating patients as they are today.

Diagnostic tests are an important tool used by health care providers across the U.S. to make sometimes difficult decisions about the best course of care and treatment for their patients. The accuracy and reliability of such tests can literally mean the difference between life and death for some patients.

In The News

Health

Voting

Health

January 14, 2022
by Dan McCue
White House Announces Plans to Distribute Home COVID Tests

WASHINGTON — Beginning Jan. 19, Americans will be able to order free at-home COVID-19 tests online from the federal government,... Read More

WASHINGTON — Beginning Jan. 19, Americans will be able to order free at-home COVID-19 tests online from the federal government, a senior White House official announced Friday afternoon. In the early going of the new program, individuals will be limited to four free tests per residential... Read More

Mask Rules Get Tighter in Europe in Winter's COVID-19 Wave

ROME (AP) — To mask or not to mask is a question Italy settled early in the COVID-19 outbreak with... Read More

ROME (AP) — To mask or not to mask is a question Italy settled early in the COVID-19 outbreak with a vigorous “yes." Now the onetime epicenter of the pandemic in Europe hopes even stricter mask rules will help it beat the latest infection surge. Other... Read More

January 12, 2022
by Reece Nations
House Rules Committee Rejects G.I. Bill Education Benefits for Vaccine Refusal

WASHINGTON — The House Rules Committee on Monday rejected an amendment to the Guard and Reserve G.I. Bill Parity Act... Read More

WASHINGTON — The House Rules Committee on Monday rejected an amendment to the Guard and Reserve G.I. Bill Parity Act that would guarantee Armed Services members discharged for refusing the COVID-19 vaccine are eligible for G.I. Bill education benefits. The Guard and Reserve G.I. Bill Parity... Read More

January 12, 2022
by Alexa Hornbeck
Reliability of Antigen Rapid Tests in Detecting Early Omicron Questioned

WASHINGTON — Beginning Jan. 15, private health insurers will be required to cover the cost of home testing kits despite... Read More

WASHINGTON — Beginning Jan. 15, private health insurers will be required to cover the cost of home testing kits despite recent concerns from elected officials and researchers over the reliability and availability of rapid antigen testing. “I’ve heard from so many people who are waiting in... Read More

January 12, 2022
by Alexa Hornbeck
COVID Pills Show Promise for Combating Severe Infection

Pfizer’s Paxlovid is the first pill treatment to combat severe COVID-19 infection, and new figures from Israel’s Ministry of Health... Read More

Pfizer’s Paxlovid is the first pill treatment to combat severe COVID-19 infection, and new figures from Israel’s Ministry of Health show the pill may hold promise in saving lives. Shortly before Christmas Day, Paxlovid was authorized for at-home treatment of high-risk COVID-19 infections in patients over... Read More

January 12, 2022
by Alexa Hornbeck
Researchers Develop mRNA-based Lyme Disease Vaccine

Yale researchers recently developed an mRNA-based Lyme disease vaccine capable of targeting antigens in tick saliva to prevent their ability... Read More

Yale researchers recently developed an mRNA-based Lyme disease vaccine capable of targeting antigens in tick saliva to prevent their ability to transmit pathogens.  According to the CDC, nearly half a million people in the U.S. are diagnosed with Lyme Disease every year. The ailment is most... Read More

News From The Well
Exit mobile version